Genetic Study of Amyotrophic Lateral Sclerosis in Norway
NCT ID: NCT05119387
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1200 participants
OBSERVATIONAL
2019-08-01
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics of Familial and Sporadic ALS
NCT00821132
Exploring the Genetics of Neuropathic Pain
NCT03862365
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
NCT00457912
Genetic Origin of Lipid Disorders
NCT00277121
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
NCT05102799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals diagnosed with ALS
Individuals diagnosed with ALS that are being followed through the Norwegian health-care system. ALS patients ( probable or definite per El-Escorial criteria)
Observation
Observation of genetic characteristics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Observation of genetic characteristics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible to consent
Exclusion Criteria
16 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ALS Norge
UNKNOWN
Helse Sor-Ost
OTHER_GOV
Sykehuset Telemark
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helle Høyer
Role: PRINCIPAL_INVESTIGATOR
Telemark Hospital Trust, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital, Department of Neurology
Bergen, , Norway
Nordland Hospital Trust, Department of Neurology
Bodø, , Norway
Vestre Viken Hospital Trust, Department of Neurology
Drammen, , Norway
Førde Hospital Trust, Department of Neurology
Førde, , Norway
Østfold Hospital Trust, Department of Neurology
Grålum, , Norway
Fonna Hospital Trust, Department of Neurology
Haugesund, , Norway
Sørlandet Hospital Trust, Department of Neurology
Kristiansand, , Norway
Innlandet Hospital Trust, Department of Neurology
Lillehammer, , Norway
Akershus University Hospital, Department of Neurology
Lørenskog, , Norway
Møre and Romsdal Hospital Trust, Department of Neurology
Molde, , Norway
Nord-Trøndelag Hospital Trust, Department of Neurology
Namsos, , Norway
Oslo University Hospital, Department of Neurology
Oslo, , Norway
Telemark Hospital, Department of Neurology
Skien, , Norway
Stavanger University Hospital, Department of Neurology
Stavanger, , Norway
University hospital of North Norway, Department of Neurology
Tromsø, , Norway
St. Olavs Hospital, Department of Neurology
Trondheim, , Norway
Vestfold Hospital Trust, Department of Neurology
Tønsberg, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ole-Bjørn Tysnes
Role: primary
Karl Bjørnar Alstadhaug
Role: primary
Ingrid Kristine Bjørnå
Role: primary
Elin Seim
Role: primary
Erika Hallerstig
Role: primary
Ineke HogenEsch
Role: primary
Unn Ljøstad
Role: primary
Grethe Kleveland
Role: primary
Trygve Holmøy
Role: primary
Åse Hagen Morsund
Role: primary
Anna Grav
Role: primary
Angelina Maniaol
Role: primary
Heidi Flemmen
Role: primary
Katrin Schlüter
Role: primary
Agnethe Eltoft
Role: primary
Gudveig Lunde Toverud
Role: backup
Geir Bråthen
Role: primary
Natasha Demic
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/1916
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.